Avanos Medical Launches CORGRIP SR System to Revolutionize Enteral Feeding Solutions
- Avanos Medical launches the CORGRIP SR System to improve enteral feeding and reduce tube dislodgement risks.
- The system features user-friendly tools for healthcare professionals, enhancing patient management and clinical outcomes.
- Avanos Medical aims to strengthen its market position while addressing critical healthcare needs through innovative solutions.
Avanos Medical Introduces Innovative CORGRIP SR System to Enhance Enteral Feeding Solutions
Avanos Medical, Inc. announces the launch of its advanced CORGRIP SR Nasogastric/Nasointestinal Tube Retention System, marking a significant enhancement to its Enteral Feeding portfolio. Designed to address the common challenges associated with traditional tape-secured feeding tubes, the CORGRIP SR utilizes a cutting-edge monofilament thread as a nasal bridle solution. This innovative design aims to significantly reduce the risk of tube dislodgement and the complications that often accompany the replacement of nasal tubes. Research highlights a troubling statistic: 40% to 63% of feeding tubes secured with standard tape can become inadvertently dislodged, leading to increased healthcare costs and patient discomfort.
Kerr Holbrook, chief commercial officer of Avanos, emphasizes the importance of the CORGRIP SR in improving patient care. He notes that the adoption of a bridle system can markedly decrease the likelihood of accidental tube removal, which in turn enhances overall tube survival rates. The system is equipped with user-friendly features, including a yellow-tipped retrieval catheter with a hollow tip, color-coded clips for easy identification, printed centimeter markings for precise placement, and a unique orange opening tool that enhances visibility and flexibility during use. Such enhancements aim to provide healthcare professionals with a reliable tool that optimizes patient management and improves clinical outcomes.
Avanos Medical’s commitment to developing clinically superior solutions is reflected in the strategic introduction of the CORGRIP SR. This product not only strengthens the company's position in the enteral feeding market but also aligns with its broader mission to address critical healthcare needs. By improving nutritional support for patients transitioning from hospital to home, Avanos plays a crucial role in promoting recovery while simultaneously contributing to the reduction of opioid use in patient care. Healthcare professionals interested in exploring the capabilities of the CORGRIP SR can find additional information and schedule onsite demonstrations through the Avanos Medical website.
In its dedication to innovation, Avanos Medical continues to develop and market recognized brands globally, maintaining leading market positions across various categories. The company actively engages with its audience through social media platforms such as X, LinkedIn, and Facebook, reinforcing its commitment to providing essential healthcare solutions. For more information about Avanos and its product offerings, visit www.avanos.com.